Intravacc and Celonic to develop and produce a novel COVID-19 vaccine

  • Combining Intravacc’s OMV-delivery platform with Covid-19 Spike proteins
  • Preclinical studies to start shortly for candidate selection and inhouse pilot scale GMP production